Literature DB >> 7359289

The steroid-croup controversy: an analytic review of methodologic problems.

W W Tunnessen, A R Feinstein.   

Abstract

The reasons for the controversy regarding the use of corticosteroids to treat croup were reviewed by evaluating nine studies for their adequacy in meeting eight methodologic standards essential for reducing bias and distortion in clinical trials. Five studies employed diagnostic criteria for croup but none stratified patients with croup into acute laryngotracheitis and spasmodic croup, the two forms which account for the large majority of cases of croup. Only four studies used adequate doses of steroids, defined as 100 mg of cortisone or an equivalent. Only two studies developed clinically relevant choices for the outcome event. Although steroids may be helpful in certain types of croup, it is impossible to reach a definite conclusion about the efficacy of steroids, since all of the studies have major inadequacies in clinical trial design.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359289     DOI: 10.1016/s0022-3476(80)80761-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Steroid therapy for croup in children admitted to hospital. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

Review 2.  Croup: a review.

Authors:  K De Boeck
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

Review 3.  Croup.

Authors:  David Wyatt Johnson
Journal:  BMJ Clin Evid       Date:  2014-09-29

Review 4.  Management of croup.

Authors:  Wendy Stannard; Chris O'Callaghan
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 5.  Croup.

Authors:  David Johnson
Journal:  BMJ Clin Evid       Date:  2009-03-10

6.  Do steroids prevent reintubation in children with laryngotracheobronchitis?

Authors:  J Rajah; J Riera-Fanego; J Keeton; A Ramjee; R Bhana; L Lasersohn; H Hon
Journal:  Crit Care       Date:  2000-08-21       Impact factor: 9.097

Review 7.  Infraglottic and bronchial infections.

Authors:  A Uba
Journal:  Prim Care       Date:  1996-12       Impact factor: 2.907

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.